Cleveland Clinic 1st use of Hugo RAS robot advances minimally invasive prostate surgery with modular arms and open-console design.
The average age of men who get diagnosed is 67.
A hospital in Surrey says it is the first NHS trust in the UK to use a "revolutionary" new device that improves prostate cancer surgery and reduces the need for radiotherapy. The Histolog Scanner ...
2don MSN
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
In the real-world, Pluvicto™ showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPC; Real‑world evidence showed Pluvicto achieved longer PFS when init ...
John Smith's new guide helps patients and caregivers manage recovery challenges, set realistic expectations, and ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
A preclinical evaluation of a new ’dual-mode’ tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and ...
According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results